FASN and breast cancer: Therefore miR-33a expression levels in the cells might be a potential diagnostic and therapeutic marker to contribute to the link between fatty acid synthase metabolism and enhanced ER+ breast cancer development, considering the mechanistic effect on breast cancer cell survival and cell death decision provided from this study (Figure 4).